CGRP binding nucleic acids

US7879991B2 · kind B2 · utility

Assignee

• NOXXON Pharma AG · DE

Inventors

• Axel Vater · Berlin, DE
• Christian Maasch · Berlin, DE
• Florian Jarosch · Berlin, DE
• Mathias Bell · Berlin, DE
• Steffen Helmling · Boston, US
• Bernd Eschgfaller · Basel, CH
• Elisabeth Moyroud · Graz, AT
• Sandra Stark · Berlin, DE
• Sven Klussmann · Berlin, DE
• Thorsten Ruppert · Berlin, DE
• Gregor Bahrenberg · Monschau, DE
• Clemens Gillen · Aachen, DE
• Klaus Schiene · Goldkronach, DE

Key dates

• Filing date: May 6, 2003
• Grant date: Feb 1, 2011
• Expiry date: Sep 21, 2025

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C12N15/115
• WIPO field: Biotechnology
• WIPO sector: Chemistry

Abstract

The invention relates to an antagonist for CGRP and amylin, whereby the antagonist is a nucleic acid and said nucleic acid binds to CGRP or amylin. Said nucleic acid preferably comprises an L-nucleotide.